These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1839936)

  • 1. [Dexamethasone therapy in Huntington chorea: preliminary results].
    Nuti A; Maremmani C; Ceravolo R; Pavese N; Bonuccelli U; Muratorio A
    Riv Neurol; 1991; 61(6):225-7. PubMed ID: 1839936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy with tetrabenazine and pimozide in Huntington's chorea: pilot study.
    McArthur AW; Pollock M; Smidt NA
    N Z Med J; 1976 Feb; 83(558):114-6. PubMed ID: 131917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic experiences in the treatment of hyperkineses with the neuroleptic pimozide (Antalon, Orap) in the frame of Huntington chorea].
    Siegmund R; Schmeisser G; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1982 May; 34(5):307-8. PubMed ID: 6213970
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sleep in chronic chorea patients after therapy with sodium valproate].
    Puca FM; Genco S; Minervini MG; Specchio LM; Napoletano V; Brancasi B; Reggio F
    Boll Soc Ital Biol Sper; 1984 May; 60(5):989-92. PubMed ID: 6235824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
    Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J
    Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study].
    Mateo D; Giménez-Roldán S
    Neurologia; 1996 Jan; 11(1):16-9. PubMed ID: 8714171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid therapy in Huntington's disease.
    Bonuccelli U; Nuti A; Maremmani C; Ceravolo R; Muratorio A
    Adv Biochem Psychopharmacol; 1992; 47():149-54. PubMed ID: 1387281
    [No Abstract]   [Full Text] [Related]  

  • 8. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
    Lal S; De la Vega C; Garelis E; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
    [No Abstract]   [Full Text] [Related]  

  • 9. Huntington's disease: clinical effects of a short-term treatment with pimozide.
    Arena R; Iudice A; Virgili P; Moretti P; Menchetti G
    Adv Biochem Psychopharmacol; 1980; 24():573-5. PubMed ID: 6447434
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of coenzyme Q10 tolerability in Huntington's disease.
    Feigin A; Kieburtz K; Como P; Hickey C; Claude K; Abwender D; Zimmerman C; Steinberg K; Shoulson I
    Mov Disord; 1996 May; 11(3):321-3. PubMed ID: 8723151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease.
    Girotti F; Carella F; Scigliano G; Grassi MP; Soliveri P; Giovannini P; Parati E; Caraceni T
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):848-52. PubMed ID: 6147393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The sleep of the chronic chorea patient after pimozide therapy].
    Puca FM; Genco S; Specchio LM; Internò S; Castriotta R; Maggiore A; Leomanni R
    Boll Soc Ital Biol Sper; 1978 Mar; 54(5):456-9. PubMed ID: 153762
    [No Abstract]   [Full Text] [Related]  

  • 13. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C; Hunter C; Davidson A; Jankovic J
    Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Haloperidol, reserpine, l-dopa and amantidine in the treatment of Huntington chorea (author's transl)].
    Candelise L
    Riv Patol Nerv Ment; 1976; 96(1):54-62. PubMed ID: 134449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].
    Giménez-Roldán S; Mateo D
    Neurologia; 1989 Oct; 4(8):282-7. PubMed ID: 2534679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.
    Saft C; Lauter T; Kraus PH; Przuntek H; Andrich JE
    BMC Neurol; 2006 Feb; 6():11. PubMed ID: 16507108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypokinesia in Huntington's disease.
    van Vugt JP; van Hilten BJ; Roos RA
    Mov Disord; 1996 Jul; 11(4):384-8. PubMed ID: 8813217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Choreic dyskinesia and GABA - pharmaco-clinical approach. Preliminary note].
    Roccatagliata G; Albano C; Besio G; Ivaldi EM
    Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):63-8. PubMed ID: 153581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology.
    Fenney A; Jog MS; Duval C
    Brain Res; 2008 Feb; 1193():67-75. PubMed ID: 18177845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of dyskinesias with tiapride (author's transl)].
    Kocher R; Hobi V
    Sem Hop; 1980 Dec 18-25; 56(47-68):2033-4. PubMed ID: 6109379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.